Kim Fligelstone

EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)

Otylia Kowal‐Bielecka, Robert Landewé, Jérôme Avouac et al. · Annals of the Rheumatic Diseases · 2009 · 617 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +11

The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy

Marco Matucci‐Cerinic, Yannick Allanore, László Czirják et al. · Annals of the Rheumatic Diseases · 2009 · 166 citations

Medicine, Pharmacotherapy, Dermatopathology +11

Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS)

Ariane L. Herrick, Xiaoyan Pan, Sébastien Peytrignet et al. · Annals of the Rheumatic Diseases · 2017 · 139 citations · Full text

Medicine, Clinical Sciences, Dermatology +14

The Scleroderma Patient-Centered Intervention Network Cohort: baseline clinical features and comparison with other large scleroderma cohorts

Dane H Dougherty, Linda Kwakkenbos, Marie‐Eve Carrier et al. · Lara D. Veeken · 2018 · 81 citations · Full text

Medicine, Immunology, Clinical Epidemiology +13

The 2024 British Society for Rheumatology guideline for management of systemic sclerosis

Christopher P. Denton, Enrico De Lorenzis, Elen Roblin et al. · Lara D. Veeken · 2024 · 78 citations · Full text

Medicine, Clinical Sciences, Health Assessment +12